subsection (d) shall affect the authority of the Attorney
General to modify thresholds (including cumulative
thresholds) for retail distributors for products other than
ordinary over-the-counter pseudoephedrine or phenyl-
propanolamine products (as defined in section 102(45) of
the Controlled Substances Act, as added by this section)
or for non-retail distributors, importers, or exporters.
(f) EFFECTIVE DATE OF THIS SECTION.—Notwith-
standing any other provision of this Act, this section shall
not 
apply 
to 
the 
sale 
of 
any 
over-the-counter
pseudoephedrine or phenylpropanolamine product initially
introduced into interstate commerce prior to 9 months
after the date of enactment of this Act.
SEC. 402. MAIL ORDER RESTRICTIONS.
Section 310(b) of the Controlled Substances Act (21
U.S.C. 830(b)) is amended by adding at the end the fol-
lowing:
‘‘(3) MAIL ORDER REPORTING.—(A) Each regu-
lated person who engages in a transaction with a
nonregulated person which—
‘‘(i) involves ephedrine, pseudoephedrine,
or phenylpropanolamine (including drug prod-
ucts containing these chemicals); and
‘‘(ii) uses or attempts to use the Postal
Service or any private or commercial carrier;
shall, on a monthly basis, submit a report of each
such transaction conducted during the previous
month to the Attorney General in such form, con-
taining such data, and at such times as the Attorney
General shall establish by regulation.
‘‘(B) The data required for such reports shall
include—
‘‘(i) the name of the purchaser;
‘‘(ii) the quantity and form of the ephed-
rine, pseudoephedrine, or phenylpropanolamine
purchased; and
‘‘(iii) the address to which such ephedrine,
pseudoephedrine, or phenylpropanolamine was
sent.’’.
TITLE V—EDUCATION AND
RESEARCH
SEC. 501. INTERAGENCY METHAMPHETAMINE TASK FORCE.
(a) ESTABLISHMENT.—There is established a ‘‘Meth-
amphetamine Interagency Task Force’’ (referred to as the
‘‘interagency task force’’) which shall consist of the follow-
ing members:
(1) The Attorney General, or a designee, who
shall serve as chair.
(2) 2 representatives selected by the Attorney
General.
(3) The Secretary of Education or a designee.
(4) The Secretary of Health and Human Serv-
ices or a designee.
(5) 2 representatives of State and local law en-
forcement and regulatory agencies, to be selected by
the Attorney General.
(6) 2 representatives selected by the Secretary
of Health and Human Services.
(7) 5 nongovernmental experts in drug abuse
prevention and treatment to be selected by the At-
torney General.
(b) RESPONSIBILITIES.—The interagency task force
shall be responsible for designing, implementing, and eval-
uating the education and prevention and treatment prac-
tices and strategies of the Federal Government with re-
spect to methamphetamine and other synthetic stimulants.
(c) MEETINGS.—The interagency task force shall
meet at least once every 6 months.
(d) FUNDING.—The administrative expenses of the
interagency task force shall be paid out of existing Depart-
ment of Justice appropriations.
(e) FACA.—The Federal Advisory Committee Act (5
U.S.C. App. 2) shall apply to the interagency task force.
(f) TERMINATION.—The interagency task force shall
terminate 4 years after the date of enactment of this Act.
SEC. 502. PUBLIC HEALTH MONITORING.
The Secretary of Health and Human Services shall
develop a public health monitoring program to monitor
methamphetamine abuse in the United States. The pro-
gram shall include the collection and dissemination of data
related to methamphetamine abuse which can be used by
public health officials in policy development.
SEC. 503. PUBLIC-PRIVATE EDUCATION PROGRAM.
(a) ADVISORY PANEL.—The Attorney General shall
establish an advisory panel consisting of an appropriate
number of representatives from Federal, State, and local
law enforcement and regulatory agencies with experience
in investigating and prosecuting illegal transactions of
precursor chemicals. The Attorney General shall convene
the panel as often as necessary to develop and coordinate
educational programs for wholesale and retail distributors
of precursor chemicals and supplies.
(b) CONTINUATION
OF CURRENT EFFORTS.—The
Attorney General shall continue to—
(1) maintain an active program of seminars and
training to educate wholesale and retail distributors
of precursor chemicals and supplies regarding the
identification of suspicious transactions and their re-
sponsibility to report such transactions; and
(2) provide assistance to State and local law en-
forcement and regulatory agencies to facilitate the
establishment and maintenance of educational pro-
grams for distributors of precursor chemicals and
supplies.
SEC. 504. SUSPICIOUS ORDERS TASK FORCE.
(a) IN GENERAL.—The Attorney General shall estab-
lish a ‘‘Suspicious Orders Task Force’’ (the ‘‘Task
Force’’) which shall consist of—
(1) appropriate personnel from the Drug En-
forcement Administration (the ‘‘DEA’’) and other
Federal, State, and local law enforcement and regu-
latory agencies with the experience in investigating
and prosecuting illegal transactions of listed chemi-
cals and supplies; and
(2) representatives from the chemical and phar-
maceutical industry.
(b) RESPONSIBILITIES.—The Task Force shall be re-
sponsible for developing proposals to define suspicious or-
ders of listed chemicals, and particularly to develop quan-
tifiable parameters which can be used by registrants in
determining if an order is a suspicious order which must
be reported to DEA. The quantifiable parameters to be
addressed will include frequency of orders, deviations from
prior orders, and size of orders. The Task Force shall also
recommend provisions as to what types of payment prac-
tices or unusual business practices shall constitute prima
facie suspicious orders. In evaluating the proposals, the
Task Force shall consider effectiveness, cost and feasibil-
ity for industry and government, an other relevant factors.
(c) MEETINGS.—The Task Force shall meet at least
two times per year and at such other times as may be
determined necessary by the Task Force.
(d) REPORT.—The Task Force shall present a report
to the Attorney General on its proposals with regard to
suspicious orders and the electronic reporting of sus-
picious orders within one year of the date of enactment
of this Act. Copies of the report shall be forwarded to the
Committees of the Senate and House of Representatives
having jurisdiction over the regulation of listed chemical
and controlled substances.
(e) FUNDING.—The administrative expenses of the
Task Force shall be paid out of existing Department of
Justice funds.
(f) FACA.—The Federal Advisory Committee Act (5
U.S.C. App. 2) shall apply to the Task Force.
(g) TERMINATION.—The Task Force shall terminate
upon presentation of its report to the Attorney General,
or two years after the date of enactment of this Act,
whichever is sooner.
Æ